Biguanide medicine · Fact sheet
Metformin
Also known as Glucophage · metformin hydrochloride
Metformin is FDA approved to improve glycemic control in type 2 diabetes, not to slow aging or extend lifespan. The anti-aging case remains a research hypothesis, and controlled studies have also found tradeoffs such as blunted muscle growth during resistance training.
What is Metformin?
Metformin is a biguanide medicine that lowers liver glucose production and improves aspects of glucose metabolism.
Its low cost, long clinical history, and effects on metabolic and cellular pathways made it a major drug-repurposing candidate in geroscience.
Benefits people look for
Observational studies in people with diabetes have associated metformin use with some favorable age-related outcomes, but treatment selection and underlying health make causal interpretation difficult.
Small trials such as MILES test biomarkers and tissue responses; they do not establish that metformin prevents aging-related disease in otherwise healthy people.
What the evidence supports
- Metformin's glucose-lowering benefits in type 2 diabetes are established.
- Geroscience studies have measured changes in gene expression and metabolic pathways, but these surrogate findings do not prove longer or healthier life.
All research areas
- Type 2 diabetes
- Cellular and metabolic aging biomarkers
- Prevention of multiple age-related diseases
- Interactions with exercise adaptation
Anecdotal reports & lived experiences
Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens.
No attributable personal reports are summarized here yet. The benefits above describe research interests; the side effects below come from the cited medical sources.
We do not fill this gap with unsourced testimonials or estimated success rates.
Side effects & risks
- FDA labeling carries a boxed warning for rare but serious lactic acidosis, with risk shaped by kidney function and other clinical factors.
- Common adverse effects are gastrointestinal; longer use can be associated with vitamin B12 deficiency.
- A randomized trial in older adults found metformin blunted muscle hypertrophy from progressive resistance training, illustrating that pathway effects may involve tradeoffs.
This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.
Clinical research: how strong is it?
Strong human evidence for approved usesThere is strong evidence for diabetes treatment, but no completed large randomized trial showing that metformin extends life or delays multiple age-related diseases in people without its established metabolic indications.
Selected research to read
Small completed mechanistic study of tissue and metabolic responses, not a lifespan trial.
Controlled trial reporting blunted muscle hypertrophy with metformin during resistance training in older adults.
FDA approval & research status
Metformin is FDA approved for glycemic control in type 2 diabetes. Aging, lifespan extension, and general healthspan enhancement are not FDA-approved indications.
Approved uses covered here
- Improving glycemic control in people with type 2 diabetes as specified in FDA-approved labeling
FDA approved for type 2 diabetes, not aging
Metformin is FDA approved for glycemic control in type 2 diabetes. Aging, longevity, and exercise-response questions remain separate research uses.
This summarizes the cited product or research record. Trial phases do not establish successful completion of earlier stages, and a stopped program is not ongoing development. Approval applies only to the labeled product, use and population.
What we still don’t know
- Whether metformin improves lifespan or healthspan in people without diabetes
- Which age, metabolic profile, or biomarker could identify a favorable risk-benefit group
- How exercise, nutrition, and other medicines modify any geroscience effect
- Whether observational associations reflect the drug or differences between patient groups
The takeaway
Metformin is an important diabetes medicine and a serious geroscience research tool. It is not a proven longevity drug for healthy people.
Sources & further reading
Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.
- 1fdaFDA prescribing information: Glucophage and Glucophage XR
Official indication, boxed warning, contraindications, and adverse reactions.
- 2clinical trialsClinicalTrials.gov: Metformin in Longevity Study
Small completed mechanistic study of tissue and metabolic responses, not a lifespan trial.
- 3pubmedMASTERS randomized exercise trial
Controlled trial reporting blunted muscle hypertrophy with metformin during resistance training in older adults.